Midatech Pharma Plc Float d'actions
Quel est le Float d'actions de Midatech Pharma Plc?
Le Float d'actions de Midatech Pharma Plc est 85.470M 134.85%
Quelle est la définition de Float d'actions ?
Le flottant des actions est la partie des actions d’une société qui est entre les mains d’investisseurs publics, par opposition aux actions immobilisées.
Shares float represents the portion of shares of a corporation that are in the hands of public investors as opposed to locked-in stock held by promoters, company officers, controlling-interest investors, or government. This number is sometimes seen as a better way of calculating market capitalization because it provides a more accurate reflection of what public investors consider the company to be worth. In this context, the float may refer to all the shares outstanding that can be publicly traded
The float is calculated by subtracting the locked-in shares from outstanding shares. Stocks with smaller floats tend to be more volatile than those with larger floats. In general, the large holdings of founding shareholders, corporate cross-holdings, and government holdings in partially privatized companies are excluded when calculating the size of a public float.
Float d'actions des entreprises dans Health Care secteur sur LSE par rapport à Midatech Pharma Plc
Que fait Midatech Pharma Plc?
Midatech Pharma plc focuses on the research and development of oncology and rare disease products in the United Kingdom, rest of Europe, and internationally. The company is developing MTX110, a direct delivery treatment for diffuse intrinsic pontine glioma, medulloblastomas, and glioblastoma multiforme; MTX114, an immuno-suppressant for topical application in psoriasis; and MTD211 and MTD219 for central nervous system and transplant anti-rejection indications. It also offers drug delivery platforms, such as Q-Sphera, a polymer microsphere microtechnology used for sustained release drug delivery; MidaSolve, an oligosaccharide nanotechnology used to solubilize drugs so that they can be administered in liquid form directly and locally into tumors; and MidaCore, a gold nanoparticle used for targeting sites of disease by using chemotherapeutic agents or immunotherapeutic agents. The company was founded in 2000 and is headquartered in Cardiff, the United Kingdom.
Entreprises avec float d'actions similaire à Midatech Pharma Plc
- Manali Petrochemicals a Float d'actions de 85.272M 49.58%
- Progressive Path a Float d'actions de 85.301M 8.22%
- The Real Brokerage Inc a Float d'actions de 85.341M 47.90%
- ITD Cementation India a Float d'actions de 85.408M 49.72%
- Asahi India Glass a Float d'actions de 85.419M 35.14%
- iTech Minerals Ltd a Float d'actions de 85.461M 72.13%
- Midatech Pharma Plc a Float d'actions de 85.470M 134.85%
- Atlantic Power a Float d'actions de 85.470M 95.27%
- Manali Petrochemicals a Float d'actions de 85.519M 49.72%
- Select Sands a Float d'actions de 85.545M 96.59%
- Greenlane Renewables a Float d'actions de 85.552M 64.60%
- Kleos Space S.A a Float d'actions de 85.562M 47.93%
- Doman Building Materials a Float d'actions de 85.563M 98.70%